<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                            NIH Public Access <br />                             Author Manuscript <br />                             Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Mol Microbiol. 2009 March ; 71(6): 1386&#226;&#8364;&#8220;1401. doi:10.1111/j.1365-2958.2009.06610.x. <br />  <br />  <br />  <br />                            Methylene tetrahydrofolate dehydrogenase/cyclohydrolase and <br />                            synthesis 10-CHO-THF essential Leishmania major <br />  <br />                            Silvane M. F. Murta*,&#194;&#167;, Tim J. Vickers*, David A. Scott&#194;&#167;&#194;&#167;, Stephen M. Beverley1 <br />                            Department Molecular Microbiology, Box 8230, Washington University School Medicine, 660 <br />                            S. Euclid Avenue, St. Louis, MO 63110, USA <br />  <br />                            Summary <br />                                 10-formyl tetrahydrofolate key metabolite C1 carbon metabolism, arising action <br />                                 formate-tetrahydrofolate ligase (FTL) and/or 5,10-methenyltetrahydrofolate cyclohydrolase/5,10- <br />                                 methylene tetrahydrofolate dehydrogenase (DHCH). Leishmania major possesses single DHCH1 <br />                                 FTL genes encoding exclusively cytosolic proteins, unlike organisms isoforms occur <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 mitochondrion well. Recombinant DHCH1 showed typical NADP+-dependent methylene <br />                                 tetrahydrofolate DH 5,10-methenyltetrahydrofolate CH activities, DH activity was <br />                                 potently inhibited substrate analog 5,10-CO-THF (Ki 105 nM), Leishmania growth <br />                                 (EC50 1.1 &#206;&#188;M). Previous studies showed null ftl&#226;&#710;&#8217; mutants normal, raising possibility that <br />                                 loss purine synthetic pathway rendered 10-CHO-THF dispensable evolution. We were <br />                                 unable generate dhch1&#226;&#710;&#8217; <span id='am-81' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-82' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-83' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-102' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-112' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-127' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span>null mutants</span> gene replacement, despite using wide spectrum of <br />                                 nutritional supplements expected bypass DHCH function. We applied improved method for <br />                                 testing essential genes Leishmania, based segregational loss episomal complementing <br />                                 genes transfection; analysis ~1400 events successful loss DHCH1 again <br />                                 established requirement. Lastly, employed &#226;&#8364;&#732;genetic metabolite complementation&#226;&#8364;&#8482; using <br />                                 ectopically expressed FTL alternative source 10-CHO-THF; dhch1&#226;&#710;&#8217; null parasites were <br />                                 readily obtained. These data establish requirement 10-CHO tetrahydrofolate metabolism L. <br />                                 major, provide genetic pharmacological validation DHCH target chemotherapy, <br />                                 potentially protozoan parasites. <br />  <br />  <br />                            Keywords <br />                                 trypanosomatid protozoa; C1-THF metabolism; 1 carbon transfer; chemotherapy; formyl methionyl- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 tRNA <br />  <br />  <br />                            Introduction <br />                                             Leishmania important pathogens infecting millions people worldwide. The symptoms <br />                                             infections range skin lesions disfiguring necrosis face, lethal <br />                                             pathology liver spleen, depending Leishmania species involved. Although <br />                                             lasting immunity possible, vaccine presently available, drugs used in <br />                                             chemotherapy suffer various deficiencies, toxicity, high cost emerging <br />  <br />  <br />                            1For correspondence. E-mail: E-mail: beverley@borcim.wustl.edu. Tel. (+1) 314-747-2632; FAX. (+1) 314-747-2634;. <br />                            *Both authors contributed equally work <br />                            &#194;&#167;Present address: Centro Pesquisas Rene Rachou, FIOCRUZ, Belo Horizonte, Minas Gerais, 30190-002, Brazil <br />                            &#194;&#167;&#194;&#167;Present address: Burnham Institute Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037 <br />                            Supplemental information &#226;&#8364;&#339;Methylene tetrahydrofolate dehydrogenase/cyclohydrolase synthesis 10-CHO-THF are <br />                            essential Leishmania major&#226;&#8364;?, Silvane M. F. Murta, Tim J. Vickers, David A. Scott, Stephen M. Beverley. <br />                             Murta et al.                                                                                               Page 2 <br />  <br />  <br />                                           resistance (Kedzierski et al., 2006, Mishra et al., 2007). Consequently, development of <br />                                           alternative therapies urgent priority. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Folate derivatives essential cellular cofactors synthesis thymidine, purines the <br />                                           amino acids glycine methionine, metabolism histidine serine (Nzila et al., <br />                                           2005, Christensen &amp; MacKenzie, 2006) mitochondrial protein synthesis the <br />                                           formylation initiator methionyl-tRNAMet (Kozak, 1983). The metabolism reduced folate <br />                                           cofactors particular drug discovery, dihydrofolate reductase (DHFR) can <br />                                           efficiently targeted anti-tumor anti-microbial chemotherapy (Nzila et al., 2005, <br />                                           Schweitzer et al., 1990, Then, 2004). While current antifolates ineffective against <br />                                           Leishmania DHFR inhibition bypassed pteridine reductase 1 (PTR1), is <br />                                           relatively insensitive (Bello et al., 1994), combined inhibitor strategies overcome this <br />                                           (Hardy et al., 1997, Cavazzuti et al., 2008). In work explore potential new arena for <br />                                           chemotherapy, enzymes responsible synthesis 10-formyl tetrahydrofolate (10- <br />                                           CHO-THF). <br />  <br />                                           Three known enzyme activities mediate production 10-CHO-THF (Fig. 1) (Christensen &amp; <br />                                           Mackenzie, 2008,Christensen &amp; MacKenzie, 2006,Appling, 1991). In pathway formate is <br />                                           added directly THF ATP-dependent reaction formate-tetrahydrofolate ligase <br />                                           (FTL, EC 6.3.4.3) (Rabinowitz &amp; Pricer, 1962). Alternatively, 10-CHO-THF arises two <br />                                           steps 5,10-methylene-tetrahydrofolate (5,10-CH2-THF), beginning oxidation <span id='am-2' about='protege:TO' typeof='owl:Thing'>to</span> <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           5,10-methenyl-tetrahydrofolate (5,10-CH=THF) NADP+ NAD+-dependent <br />                                           methylenetetrahydrofolate dehydrogenase (DH, EC 1.5.1.5 1.5.1.15, respectively) (Moore <br />                                           et al., 1974,Hatefi et al., 1957). 5,10-CH=THF hydrolyzed 10-CHO-THF by <br />                                           methenyltetrahydrofolate cyclohydrolase (CH, EC 3.5.4.9). These enzymes occur physically <br />                                           various combinations, monofunctional enzymes human, bacterial plant <br />                                           FTLs, bifunctional enzymes dehydrogenase cyclohydrolase activities (referred as <br />                                           DHCH enzymes), trifunctional enzymes activities (referred C1-THF <br />                                           synthases) (Christensen &amp; Mackenzie, 2008,Christensen &amp; MacKenzie, 2006,Appling, <br />                                           1991,Nour &amp; Rabinowitz, 1991,Tan et al., 1977). Adding complexity, multiple genes <br />                                           encode activities single organism, humans expressing trifunctional <br />                                           C1-synthase cytoplasm (MTHFD1), bifunctional DHCH (MTHFD2) a <br />                                           monofunctional FTL (MTHFD1L) targeted mitochondrion (Christensen et al., 2005b). <br />                                           Other eukaryotes express differing combinations cytosolic organellar DHCH and <br />                                           FTLs (Christensen &amp; MacKenzie, 2006,Hanson &amp; Roje, 2001). <br />  <br />                                           The products enzymes known functions. 5,10-CH=THF best- <br />                                           known intermediate leading 10-CHO-THF (Hanson &amp; Roje, 2001, Christensen &amp; <br />                                           MacKenzie, 2006, Appling, 1991), occurs DNA photolyases, and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           functions mammalian histidine catabolism (Weber, 2005, Stanger, 2002). These pathways <br />                                           described Leishmania properties organisms suggest they <br />                                           unlikely essential. 10-CHO-THF acts formyl donor purine biosynthesis, and <br />                                           bacteria eukaryotic organelles formylation initiator methionyl-tRNAMet to <br />                                           produce fMet-tRNAMet (Appling, 1991, Christensen &amp; MacKenzie, 2006, RajBhandary, <br />                                           1994, Varshney et al., 1993, Kozak, 1983). Interestingly, protozoans including <br />                                           trypanosomes Leishmania lack novo purine pathway rely exclusively salvage <br />                                           (Carter et al., 2008), eliminating need 10-CHO-THF capacity. The importance <br />                                           initiator Met-tRNAMet formylation subject controversy. While thought <br />                                           originally essential bacteria, recent data suggest case (Newton <br />                                           et al., 1999, RajBhandary, 2000). Mitochondrial initiator Met-tRNAMet formylation is <br />                                           dispensable yeast Saccharomyces cerevisae required humans; when <br />                                           essential, consequences loss vary widely (Li et al., 2000, Spencer &amp; Spremulli, <br />                                           2004, Vial et al., 2003). Studies protozoal parasite Trypanosoma brucei, member of <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                              Page 3 <br />  <br />  <br />                                           protozoal subfamily Trypanosomatidae Leishmania belongs, Met-tRNA <br />                                           imported mitochondrion formylated, used mitochondrial <br />                                           protein synthesis (Tan et al., 2002, Charriere et al., 2005). RNAi knockdown formyl- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Met-tRNAMet transferase (FMT) shows little <span id='am-159' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-160' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-161' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-163' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-164' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-170' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-184' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-203' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-209' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-216' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-226' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-234' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-235' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span>phenotype</span>. However, negative results RNAi <br />                                           knockdowns arise incomplete inhibition, particular problem in <br />                                           cofactor metabolism low levels THF-dependent metabolites fulfill normal <br />                                           metabolic needs. Importantly, simultaneous RNAi knockdown T. brucei FMT the <br />                                           mitochondrial initiation factor IF2 yield significant growth inhibition (Charriere et al., 2005), <br />                                           possibly signifying importance fMet-tRNAMet essential mitochondrial protein <br />                                           synthesis. <br />  <br />                                           Previously used database mining survey 10-CHO-THF synthetic pathway <br />                                           Leishmania trypanosomatids (Vickers et al., 2008, Opperdoes &amp; Coombs, <br />                                           2007). The L. major genome encodes active monofunctional FTL predicted <br />                                           bifunctional DHCH encoded DHCH1 gene. Both proteins localized exclusively <br />                                           cytoplasm consistent absence predicted N terminal mitochondrial targeting <br />                                           sequence, shown immunoblotting cellular fractions GFP fusions to <br />                                           DHCH1 (Vickers et al., 2008). Unexpectedly, ftl&#226;&#710;&#8217; null mutants showed normal viability and <br />                                           virulence. As noted above, absence purine synthesis mitigates need 10-CHO- <br />                                           THF Leishmania, potentially reduce eliminate requirement <br />                                           globally. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Here characterize role DHCH1 L. major metabolism enzymatic, genetic <br />                                           <span id='am-237' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-238' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-239' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-240' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-242' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-243' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-244' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-246' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-251' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-252' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-253' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-254' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-255' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-261' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-264' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-266' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-269' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-273' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-274' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-275' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-278' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-279' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-280' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-282' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-283' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-285' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-287' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-288' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-290' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-297' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-299' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-301' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-302' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-304' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-305' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-306' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-307' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-308' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-310' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-313' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-314' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span>knockout</span>, pharmacological tests. First DHCH1 encodes functional protein <br />                                           NADP-dependent DH CH activities, kinetic properties similar seen in <br />                                           organisms. We used traditional transfection-based new plasmid segregational <br />                                           approach establish DHCH1 essential. Notably, over-expression FTL enabled the <br />                                           recovery dhch1&#226;&#710;&#8217; mutants, establishing &#226;&#8364;&#732;genetic metabolite complementation&#226;&#8364;&#8482; that <br />                                           10-CHO-THF essential. Lastly showed Leishmania growth DHCH1 activity can <br />                                           inhibited specific DHCH inhibitor. In total data provide genetic and <br />                                           pharmacological validation DHCH target anti-parasitic chemotherapy. <br />  <br />                               Results <br />                               Enzymatic activity recombinant L. major DHCH1 <br />                                           Previously used database mining trypanosomatid genomes identify gene LmjF26.0320 <br />                                           DHCH1 functional DHCH Leishmania major (Vickers et al., 2008). A <br />                                           hexahistidine-tagged DHCH1 expressed E. coli recombinant protein was <br />                                           purified metal-affinity chromatography (Supplementary Figure S1) (Vickers et al., 2008). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Dehydrogenase activity measured following conversion 5,10-CH2-THF 5,10- <br />                                           CH=THF, cyclohydrolase activity monitored following consumption of <br />                                           5,10-CH=THF, yielding 10-CHO-THF (see methods). Purified DHCH1 showed 5,10- <br />                                           CH2-THF dehydrogenase 5,10-CH=THF cyclohydrolase activities, specific activities <br />                                           22 &#194;&#177; 2 6.3 &#194;&#177; 0.8 &#206;&#188;mol min&#226;&#710;&#8217;1 mg&#226;&#710;&#8217;1, respectively. In comparison activities the <br />                                           porcine cytosolic multifunctional C1-synthase L. major enzyme slightly higher <br />                                           dehydrogenase activity lower cyclohydrolase activity, porcine enzyme having <br />                                           activities 7.5 22 &#206;&#188;mol min&#226;&#710;&#8217;1 mg&#226;&#710;&#8217;1, respectively (Tan et al., 1977). <br />  <br />                                           The kinetic properties dehydrogenase reaction determined summarized in <br />                                           Table 1. The reaction followed typical Michaelis-Menten kinetics saturated with <br />                                           substrate. In mammals, cytoplasmic DH activity trifunctional C1-synthase is <br />                                           dependent NADP+ (Tan et al., 1977), mitochondrial DH dependent NAD <br />                                           + (Mejia &amp; MacKenzie, 1988). The L. major DHCH1 dehydrogenase activity highly <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                               Page 4 <br />  <br />  <br />                                           dependent NADP+, activity detected NAD+ (limit detection 0.3 &#206;&#188;mol <br />                                           min&#226;&#710;&#8217;1 mg&#226;&#710;&#8217;1, 1% activity seen NADP+). While DH activity human <br />                                           mitochondrial DHCH NAD+ requires phosphate magnesium ions (Christensen et <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           al., 2005a), tested presence 5 mM (K+)PO4 5 mM MgCl2 L. major <br />                                           DHCH1 showed NAD+-dependent activity (data shown). These data consistent <br />                                           conservation residues LmDHCH1 interact NADP+ cofactor the <br />                                           human cytosolic enzyme, notably Arg173 interacts coenzyme 2&#226;&#8364;&#8482; phosphate group <br />                                           human enzyme&#226;&#8364;&#8482;s active site (Allaire et al., 1998) (Fig. S2). In comparison human <br />                                           enzymes, Leishmania DHCH1 dehydrogenase activity appears similar the <br />                                           NADP+-dependent cytoplasmic C1 synthase, lower Km coenzyme lower <br />                                           turnover human mitochondrial DHCH MTHFD2 (Pawelek &amp; MacKenzie, 1998). <br />  <br />                               Attempts generate DHCH1 knockout &#226;&#8364;&#732;classic&#226;&#8364;&#8482; double replacements <br />                                           Leishmania predominantly diploid inactivation genes requires rounds <br />                                           gene replacement (Cruz et al., 1991). While chromosomes aneuploidy some <br />                                           WT Leishmania strains, preliminary CGH data suggest Chromosome 26 bearing <br />                                           DHCH1 disomic L. major line studied (E. Kruvand S. Beverley, in <br />                                           preparation). Thus, constructed targeting fragments, DHCH1 ORF replaced <br />                                           ones encoding puromycin (PAC) hygromycin B (HYG) resistance, flanked ~ 1 kb of <br />                                           5&#226;&#8364;&#178; 3&#226;&#8364;&#178; sequence (Fig. 2A). Electroporation fragment separately WT L. major <br />                                           followed plating selective media yielded transfectant colonies efficiently control <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           frequencies (not shown). Analysis 20 clonal transfectant lines showed were <br />                                           heterozygotes (DHCH1/&#206;&#8221;dhch1::PAC DHCH1/&#206;&#8221;dhch1::HYG, abbreviated as <br />                                           PAC/+ HYG/+) expected (Fig 2A, Supplementary Figure S3, data shown). These <br />                                           studies used PCR tests primer pairs containing located outside targeting <br />                                           fragment 5&#226;&#8364;&#178; 3&#226;&#8364;&#178; side, partnered marker-specific primer (Fig. S3, 2B, 2C <br />                                           data shown). <br />  <br />                                           Next HYG/+ PAC/+ heterozygotes submitted second round electroporation <br />                                           remaining targeting fragment (PAC HYG respectively) plated semisolid <br />                                           media containing puromycin hygromycin B. PCR tests 12 doubly resistant clonal <br />                                           transfectant lines showed contained planned HYG PAC DHCH1 <br />                                           replacements (Fig 2B, 2C). Nonetheless, clonal transfectants retained copy DHCH1, <br />                                           revealed PCR amplification intact DHCH1 ORF (Fig. 2D), grew normally (data <br />                                           shown). This finding successful &#226;&#8364;&#732;double replacement&#226;&#8364;&#8482; accompanied retention the <br />                                           WT gene seen previously attempts target essential genes Leishmania, <br />                                           arising generation aneuploid tetraploid parasites additional chromosomes <br />                                           bearing target gene (Balana-Fouce et al., 2008, Cruz et al., 1993, Dumas et al., 1997, Ilgoutz <br />                                           et al., 1999a, Vergnes et al., 2005). Analysis DNA content doubly-targeted lines <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           flow cytometry showed WT DNA contents (data shown), suggested these <br />                                           likely aneuploids, bearing &#226;&#8364;&#732;WT&#226;&#8364;&#8482; chromosome planned <br />                                           HYG PAC replacements (Fig. 2A). <br />  <br />                               Attempts generate DHCH1 knockout double replacement using different nutritional <br />                               supplements <br />                                           We attempted bypass consequences DHCH1 ablation metabolic <br />                                           complementation. In studies, 2nd round transfections repeated, with <br />                                           parasites grown plated media containing various supplements potentially able bypass <br />                                           DHCH1 requirement. First included metabolites known participate and/or arise in <br />                                           C1 folate metabolism, including glycine, serine, formate, tetrahydrofolate, thymidine and <br />                                           folinic acid. Second, parasites grown supplements plus C1 folates <br />                                           5,10-CH=THF 10-formylfolic acid (10-CHOFA), intermediate <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                             Page 5 <br />  <br />  <br />                                           metabolite formed DH activity DHCH1 second constituting potential <br />                                           precursor 10-formyl-THF. While ideal supplement 10-CHO-THF, this <br />                                           metabolite unstable; however, mildly alkaline pH Leishmania culture media <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           (7.4), spontaneous isomerization 5,10-CH=THF 10-CHO THF occurs time <br />                                           (Rabinowitz, 1963, Brouwer et al., 2007). Lastly, expected role 10-CHO-THF in <br />                                           Leishmania arises role mitochondrial protein synthesis, attempted bypass <br />                                           potential requirement performing transfections presence pyruvate uridine, <br />                                           metabolites proposed bypass need mitochondrial DNA and <br />                                           presumably proteins encoded (Sen et al., 2007). <br />  <br />                                           In total, 65 independent clonal lines analyzed, yielded presumptive <br />                                           aneuploidy phenotype PCR assay described (data shown), i.e. parasites <br />                                           bearing planned HYG PAC replacements retaining copy the <br />                                           DHCH1 ORF, recovery dhch1&#226;&#710;&#8217; null mutants. <br />  <br />                               Deletion chromosomal DHCH1 presence ectopically expressed DHCH1 <br />                                           An important control successful targeting achieved presence of <br />                                           ectopic DHCH1 expression, render unlikely possibility molecular events <br />                                           anticipated tested strategy occurred. First, DHCH1 expressed <br />                                           multicopy episomal pXNG4 vector, bears nourseothricin (SAT) resistance <br />                                           marker (D. Scott S. Beverley, preparation). DHCH assays WT protein extracts showed <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           specific activity 1 nmol&#226;&#710;&#8217;1 min&#226;&#710;&#8217;1 mg, value significantly different assay <br />                                           background controls lacking NADP+, WT/pXNG4-DHCH1 transfectants showed <br />                                           specific activity 31 nmol&#226;&#710;&#8217;1 min&#226;&#710;&#8217;1 mg, 30-fold greater. pXNG4-DHCH1 then <br />                                           introduced HYG/+ PAC/+ heterozygotes described previously, second <br />                                           chromosomal allele lines targeted transfection (Fig. 3A). To visualize the <br />                                           chromosomal DHCH1 allele, PCR using forward primer located 5&#226;&#8364;&#178; outside the <br />                                           DHCH1 targeting fragment reverse primer located DHCH1 ORF used <br />                                           (Fig. 3B). <br />  <br />                                           In contrast results parasites lacking ectopic DHCH1 expression, the <br />                                           chromosomal DHCH1 readily lost 12 independent clonal transfectants tested <br />                                           (Fig. 3B). PCR tests showed lines contained HYG PAC &#206;&#8221;dhch1&#226;&#710;&#8217; <br />                                           replacements, retaining DHCH1 ORF borne pXNG4-DHCH1 (data shown). <br />                                           Thus, presence ectopically expressed DHCH1, chromosomal DHCH1 alleles <br />                                           successfully eliminated, yielding parasites genetically dhch1&#226;&#710;&#8217;/+pXNG4- <br />                                           DHCH1. These methodological controls support conclusion the <br />                                           conditions tested, DHCH1 essential. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Genetic metabolite complementation permits recovery DHCH1 replacement <br />                                           A requirement DHCH1 somewhat surprising, Leishmania possess second <br />                                           cytoplasmic pathway 10-CHO-THF synthesis formyl tetrahydrofolate ligase <br />                                           (FTL), enzymatic activity verified (Vickers et al., 2008) (Fig. 1). This could <br />                                           indicate DHCH1 unanticipated function, alternatively, activity the <br />                                           FTL pathway insufficient metabolic needs absence DHCH1. Indeed, evidence <br />                                           FTL pathway secondary importance comes fact ftl&#226;&#710;&#8217; mutants could <br />                                           readily generated apparent effect growth vitro virulence animal <br />                                           infections (Vickers et al., 2008). <br />  <br />                                           Thus asked provision 10-CHO-THF over-expression FTL using the <br />                                           multicopy episomal vector pXNG4-FTL bypass requirement DHCH1 (Fig. 4A). <br />                                           pXNG4-FTL introduced heterozygous +/PAC +/HYG lines, FTL over- <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                               Page 6 <br />  <br />  <br />                                           expression confirmed western blot analysis (Supplementary Figure S4). These parasites <br />                                           submitted second round targeting before. Analysis 12 independent <br />                                           transfectant lines showed lacked DHCH1 ORF entirely, western blot <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           analysis polyclonal anti-DHCH1 antiserum confirmed complete loss DHCH1 <br />                                           protein (Fig. 4B, C). The ability elevated FTL expression enable parasites readily <br />                                           dispense DHCH1 strong evidence genetic metabolite complementation, presumably <br />                                           product FTL activity, 10-CHO-THF, turn argues strongly essential <br />                                           role DHCH1 provision metabolite. <br />  <br />                               Forcing loss pXNG4-DHCH1 negative selection <br />                                           As final test probing essentiality DHCH1 WT Leishmania, applied method <br />                                           building &#226;&#8364;&#732;plasmid shuffling&#226;&#8364;&#8482; approaches common yeast genetics. Plasmid segregation <br />                                           based approaches advantage allowing separation tests gene function <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> <br />                                           transfection, relatively inefficient (D. Scott S.M. Beverley, preparation). In our <br />                                           studies utilized features episomal pXNG4 vector, presence both <br />                                           negative selective marker (a modified HSV thymidine kinase gene) positive GFP <br />                                           fluorescence marker (Fig. 5A). The starting point dhch1&#226;&#710;&#8217;/pXNG4-DHCH1 parasite <br />                                           described earlier, chromosomal DHCH1 ablated parasite growth maintained <br />                                           episomal pXNG4-DHCH1 (Fig. 3, 5A). <br />  <br />                                           dhch1&#226;&#710;&#8217;/pXNG4-DHCH1 parasites grown briefly (24 h, ~3 doublings) absence <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           nourseothricin (selective SAT marker episomal pXNG4) presence of <br />                                           ganciclovir, action HSV TK selects parasites bearing pXNG4. <br />                                           Over period little effect parasite growth seen. Then, parasites subjected to <br />                                           flow cytometry, assess plasmid copy number following expression GFP marker. <br />                                           Two populations cells evident following treatment: first, &#226;&#8364;&#732;bright&#226;&#8364;&#8482; cells showing <br />                                           strong fluorescence (&gt;200 FU; M2 gate Fig. 5B) presumably high copy numbers of <br />                                           pXNG4-DHCH1; &#226;&#8364;&#732;dim&#226;&#8364;&#8482; cells, showing background fluorescence (2&#226;&#8364;&#8220;20 FU; M1 gate in <br />                                           Fig. 5B), presumably lacking pXNG4-DHCH1, bearing just copies. Controls <br />                                           showed absence ganciclovir dhch1&#226;&#710;&#8217;/+pXNG4-DHCH1 parasites retained high <br />                                           GFP fluorescence, WT cells showed background fluorescence (Fig. 5C, 5D). As <br />                                           previous results indicated DHCH1 essential, expected &#226;&#8364;&#732;bright&#226;&#8364;&#8482; cells <br />                                           retaining pXNG4-DHCH1 viable, &#226;&#8364;&#732;dim&#226;&#8364;&#8482; cells suffer growth <br />                                           disadvantage perish. <br />  <br />                                           We used flow cytometry select single cells individual wells 96 microtiter plate, <br />                                           focusing &#226;&#8364;&#732;dim&#226;&#8364;&#8482; (M1) &#226;&#8364;&#732;bright&#226;&#8364;&#8482; (M2) parasites M1 population shown Fig. <br />                                           5B. We inoculated parasites plates containing M199 media containing puromycin and <br />                                           hygromycin B (to guarantee retention dhch1&#226;&#710;&#8217; cells) lacking ganciclovir nourseothricin <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           (pXNG4 markers). Several experiments performed media supplemented additionally <br />                                           various metabolites described earlier. <br />  <br />                                           In studies, 478/672 wells inoculated single &#226;&#8364;&#732;bright&#226;&#8364;&#8482; parasite grew (71 <br />                                           %), value similar seen controls probing effects sorting, recovery growth <br />                                           single cells cells (50 &#226;&#8364;&#8220; 80%). In contrast, wells receiving single &#226;&#8364;&#732;dim&#226;&#8364;&#8482; parasite, <br />                                           growth seen 48/2016 (2.4 %) (Fig. 5B). Importantly, 48 &#226;&#8364;&#732;dim&#226;&#8364;&#8482; parasite lines <br />                                           retained pXNG4-DHCH1 plasmid, judged ability grow presence of <br />                                           nourseothricin (SATR) and/or DHCH1 PCR tests. We presume cells arose by <br />                                           imperfect sorting, and/or cells originally expressing low levels GFP presence <br />                                           copies pXNG4-DHCH1. After correcting intrinsic plating <br />                                           efficiency, estimate total approximately 1430 cells (71% 2016) scored <br />                                           ability grow absence DHCH1. Thus plasmid shuffling enabled extend <br />  <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                              Page 7 <br />  <br />  <br />                                            stringency selection total 65 events scored &#226;&#8364;&#732;classic&#226;&#8364;&#8482; transfection <br />                                            based approach, value 20-fold higher. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Interaction L. major DHCH1 novel antifolates <br />                                            To corroborate conclusion DHCH activity essential Leishmania growth, we <br />                                            turned pharmacological tests. The substrate analogue 5,10-CO-THF ((2S)-2-[[4-[(6aR)-3- <br />                                            amino-1,9-dioxo-5,6,6a,7-tetrahydro-4H- imidazol[3,4-f]pteridin-8-yl]benzoyl]amino] <br />                                            pentanedioic acid) previously shown potent inhibitor DHCH activity the <br />                                            human cytosolic C1-synthase (Tonkinson et al., 1998, Temple et al., 1982). We predicted that <br />                                            compound potent inhibitor Leishmania DHCH1, based overall <br />                                            sequence conservation, including residues shown intact inhibitor structural <br />                                            studies human C1-synthase DHCH domain (Schmidt et al., 2000) (Fig. S2). Indeed, <br />                                            5,10-CO-THF potent inhibitor DH activity recombinant Leishmania DHCH1, <br />                                            data fitting simple competitive model respect 5,10-CH2-THF, giving a <br />                                            Ki 105 &#194;&#177; 2 nM (Fig. 6). This 10-fold higher Ki 18 &#194;&#177; 5 nM seen the <br />                                            DH activity human cytosolic C1-synthase (Schmidt et al., 2000). While 5,10-CO-THF <br />                                            shown previously weak inhibitor human DHFR (Ki &gt; 100 &#206;&#188;M) (Temple et <br />                                            al., 1982), 100 &#206;&#188;M 5,10-CO-THF did inhibit activity Leishmania DHFR-TS (data <br />                                            shown) FTL (Vickers et al., 2008). L. major DHCH1 inhibited pteridine <br />                                            analogues shown previously inhibit L. major DHFR PTR1, including methotrexate or <br />                                            hydrophobic diamino-quinazoline, -pyrimidine -pteridine analogues (compound 34: 2,4- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            diamino-6-(3,4-dichlorophenoxy)-quinazoline); compound 70; 2,4-diamino-6-benzyl-5-(3- <br />                                            phenylpropyl)-pyrimidine compound 25 (2,4-diamino-6,7-diisopropylpteridine) (Hardy <br />                                            et al., 1997, Bello et al., 1994) (tested 50 &#206;&#188;M; data shown). <br />  <br />                               Toxicity folate analogues cell lines <br />                                            5,10-CO-THF inhibited L. major growth EC50 1.1 &#194;&#177; 0.04 &#206;&#188;M (Table 2). Parasites <br />                                            overexpressing DHCH1 (WT/pXNG4-DHCH1 dhch1&#226;&#710;&#8217;/+pXNG4-DHCH1) showed 4&#226;&#8364;&#8220;5 <br />                                            fold resistance (p &lt; 0.0001 p &lt; 0.0003, respectively; Table 2), consistent studies <br />                                            purified DHCH above. Parasites overexpressing FTL (WT/pXNG4-FTL dhch1&#226;&#710;&#8217;/pXNG4- <br />                                            FTL) showed 3-fold resistance (p &lt; 0.0001 p &lt; 0.0002, respectively; Table 2), implying <br />                                            FTL activity act metabolic by-pass DHCH inhibition. Consistent the <br />                                            enzyme inhibition data, DHCH1 FTL overexpressors did resistance to <br />                                            methotrexate hydrophobic antifolates tested (compounds 34 70; Table <br />                                            2). Interestingly, absence DHCH target (dhch1&#226;&#710;&#8217;/pXNG4-FTL line), growth <br />                                            inhibited EC50 &#206;&#188;M range (Table 2), suggesting 5,10-CO-THF other <br />                                            targets Leishmania. FTL excluded sensitive 5,10-CO-THF, while <br />                                            bridged structure inhibitor does closely resemble 10-CHO-THF, seems <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            probable target folate-dependent enzymes transporters the <br />                                            cell. <br />  <br />                               Discussion <br />                                            We L. major expresses active bifunctional NADP+-dependent DHCH <br />                                            encoded DHCH1 (Table 1). Previous studies localized DHCH1 protein parasite <br />                                            cytosol, consistent predicted lack N terminal mitochondrial targeting sequence <br />                                            NADP dependency DH activity (Vickers et al., 2008). Attempts generate <br />                                            dhch1&#226;&#710;&#8217; null mutants homologous replacement unsuccessful, despite analysis large <br />                                            number independent events use metabolic supplements shown organisms <br />                                            rescue DHCH-deficiency. Instead, studies invariably yielded parasites bearing two <br />                                            planned replacements, bearing extra copies DHCH1 likely arose through <br />                                            aneuploidy. The unusual Leishmania phenotype recovery planned replacements, but <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                             Page 8 <br />  <br />  <br />                                           retention target gene aneuploidy tetraploidy, widely used an <br />                                           indication gene gene essential organism. As technical control, chromosomal <br />                                           dhch1&#226;&#710;&#8217; replacements readily obtained ectopic expression DHCH1. Lastly, we <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           applied plasmid shuffling approach allowed increase number events analyzed <br />                                           20 fold: 65 classic transfectional approaches, 1,400 negative <br />                                           selection cell sorting. However, unable recover viable dhch1&#226;&#710;&#8217; null mutant <br />                                           (the virtues potential &#226;&#8364;&#732;plasmid shuffle&#226;&#8364;&#8482; methodology Leishmania discussed <br />                                           below). Thus confident concluding DHCH1 essential gene L. <br />                                           major circumstances. <br />  <br />                                           Notably, able completely remove DHCH1 following ectopic expression FTL, <br />                                           provides alternative metabolic route 10-CHO-THF synthesis formate <br />                                           tetrahydrofolate ligase activity. This form &#226;&#8364;&#732;genetic metabolic complementation&#226;&#8364;&#8482; suggests <br />                                           parasite dependency DHCH1 activity arises provision ultimate <br />                                           metabolite FTL DHCH1, 10-CHO-THF. Hypothetically, active metabolite <br />                                           5,10-CH=THF, metabolites interconvert significant rates under <br />                                           physiological conditions, precludes measurement individual abundance in <br />                                           cell (Brouwer et al., 2007). However, known essential role metabolism <br />                                           5,10-CH=THF, intermediate 10-CHO-THF synthesis, favor <br />                                           conclusion 10-CHO-THF relevant metabolite. <br />  <br />                                           Interestingly, levels WT FTL activity appear insufficient rescue dhch1&#226;&#710;&#8217; parasites, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           consistent previous finding null mutant ftl&#226;&#710;&#8217; parasites phenotypically normal <br />                                           grown vitro fully infective susceptible mice (Vickers et al., 2008). <br />                                           Hypothetically, possible elevated FTL synthesis alterations 10-CHO-THF <br />                                           metabolism bypass requirement DHCH1 circumstances, indeed <br />                                           studies able detect second site mutations including FTL gene <br />                                           amplification selections forcing loss DHCH1 (S. Murta S. Beverley, <br />                                           unpublished data). <br />  <br />                               What role 10-CHO-THF Trypanosomatid metabolism? <br />                                           In mammals, known roles 10-CHO-THF include provision formyl groups purine <br />                                           biosynthesis, intermediate C1-THF interconversions involved amino acid metabolism <br />                                           (glycine, methionine, histidine, serine), production fMet- tRNAMet the <br />                                           mitochondrion (Appling, 1991, Christensen &amp; MacKenzie, 2006). However, Leishmania are <br />                                           known purine auxotrophs genome lacks purine biosynthetic enzymes <br />                                           glycinamide ribonucleotide (GAR) phosphoribosylaminoimidazolecarboxamide <br />                                           (AICAR) transformylases (EC 2.1.1.2 2.1.2.3 respectively) (Carter et al., 2008). Similarly, <br />                                           studies established Leishmania require amino acids arising through <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           C1-pathway normal growth (Scott et al., 2008, Vickers et al., 2008). Thus the <br />                                           conditions tested, formylation initiator Met-tRNAMet currently stands only <br />                                           candidate essential metabolic role. As discussed earlier, extent fMet- tRNAMet <br />                                           synthesis required matter debate, differences seen studies within <br />                                           species eukaryotes prokaryotes. However, conclusion that <br />                                           Leishmania require fMet-tRNAMet consistent finding related <br />                                           trypanosomatid parasite T. brucei requires formylated initiator methionyl-tRNAMet for <br />                                           mitochondrial protein synthesis <span id='am-3' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-4' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-5' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span>survival</span> (Tan et al., 2002, Charriere et al., 2005). This <br />                                           suggest cytoplasmic 10-CHO-THF arising FTL DHCH1 activity <br />                                           cytosol transported mitochondrion. While generally thought that <br />                                           metabolites reduced folates principal route communication cytosolic- <br />                                           mitochondrial C1-dependent pathways mammalian cells (Appling, 1991), studies <br />  <br />  <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                   Page 9 <br />  <br />  <br />                                           point trafficking C1 tetrahydrofolates cytosol mitochondrion plants <br />                                           (Prabhu et al., 1998, Hanson et al., 2000). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           The interpretations rest strength accuracy current genome-based models <br />                                           Trypanosomatid metabolomes. Given substantial number hypothetical proteins of <br />                                           unknown function encoded Trypanosomatid genomes (Peacock et al., 2007, Ivens et al., <br />                                           2005, El-Sayed et al., 2005, Berriman et al., 2005), exclude possibility that <br />                                           Leishmania possess novel essential pathways require 10-CHO-THF. Indeed, L. <br />                                           major genome predicts highly degenerate pseudogene (pseDHCH2) DHCH2-related <br />                                           sequences completely absent L. braziliensis African trypanosome genomes <br />                                           (Peacock et al., 2007, Ivens et al., 2005, El-Sayed et al., 2005, Berriman et al., 2005). In contrast, <br />                                           seemingly intact DHCH2s occur L. infantum, L. mexicana, Crithidia fasciculata and <br />                                           Trypanosoma cruzi, predicted proteins conservation DHCH active site residues <br />                                           (Vickers et al., 2008). Interestingly, GFP tagged LiDHCH2 localized mitochondrion <br />                                           expressed L. donovani (Vickers et al., 2008), able to <br />                                           demonstrate DHCH activity associated over-expression WT LiDHCH2 (data not <br />                                           shown). Potentially occurrence catalytically active DHCH2 signify increased <br />                                           importance mitochondrial 10-CHO-THF synthesis trypanosomatid species. In the <br />                                           future, direct studies mitochondrial fMet-tRNAMet synthesis mediated FMT whether <br />                                           DHCH2 enzymatically active trypanosomatids possess test these <br />                                           hypotheses. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Plasmid segregation shuffling improved test gene function <br />                                           Currently, standard approach determining gene essential Leishmania an <br />                                           inability delete chromosomal alleles <span id='am-393' about='Thesaurus:Homologous_Gene' typeof='owl:Thing'>homologous gene</span> replacement (Cruz et al., <br />                                           1991, Barrett et al., 1999). Fortunately, studies facilitated fact homologous <br />                                           recombination occurs far frequently non-homologous insertions trypanosomatids <br />                                           (Beverley, 2003, Clayton, 1999). Ignoring technical failures, general experience most <br />                                           investigators attempts delete essential genes Leishmania yield parasites <br />                                           bearing planned allelic replacements containing additional gene copies arise via <br />                                           aneuploidy polyploidy (Cruz et al., 1993, Dumas et al., 1997, Ilgoutz et al., 1999b, Vergnes <br />                                           et al., 2005, Balana-Fouce et al., 2008). This considered diagnostic criterion, <br />                                           especially accompanied successful replacement presence ectopic gene. <br />  <br />                                           One challenge gene replacement-based approach relative inefficiency of <br />                                           transfection (10&#226;&#710;&#8217;4 less), limiting number events scored. For example, here <br />                                           analyzed 65 events targeting copy DHCH1, number exceeding typically <br />                                           reported tests Leishmania gene function. Other factors impinging replacement-based <br />                                           approaches include transfection efficiencies vary greatly depending locus and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           targeting construct used (Papadopoulou &amp; Dumas, 1997), survivors emerge <br />                                           mutations unrelated targeted gene (unpublished data). In contrast, plasmid <br />                                           shuffling approach, functional tests arise segregation ectopically expressed gene <br />                                           borne plasmid bearing positive (GFP) negative (TK) markers, line previously <br />                                           engineered lack gene (Fig. 5). Following brief period culture allow <br />                                           segregation episomal vector, large number candidate &#226;&#8364;&#732;segregants&#226;&#8364;&#8482; obtained <br />                                           appropriate manipulations GFP TK markers, rapidly tested. This allowed <br />                                           rapidly score ~1400 segregants DHCH1, 20 times number achieved <br />                                           traditional methods, necessary tested. Thus believe <br />                                           plasmid segregation method provides significant improvement tests essential <br />                                           gene function Leishmania, established yeast Saccharomyces cerevisiae <br />                                           (Forsburg, 2001). In future envisage number applications based the <br />                                           approach &#226;&#8364;&#732;plasmid shuffling&#226;&#8364;&#8482;. <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                             Page 10 <br />  <br />  <br />                               DHCH1 10-CHO-THF metabolism target anti-parasitic chemotherapy <br />                                           L. major folate metabolism shows differences human hosts, including <br />                                           bifunctional dihydrofolate reductase-thymidylate synthase (DHFR-TS) (Coderre et al., <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           1983), novel pteridine reductase (PTR1) (Bello et al., 1994), large complex family of <br />                                           folate biopterin transporters (Ouellette et al., 2002), cytosolic mitochondrial <br />                                           synthesis 10-CHO-THF (Vickers et al., 2008), others. These factors contribute to <br />                                           profound differences antifolate sensitivity; example, relative insensitivity PTR1 <br />                                           antifolates ability act metabolic bypass DHFR inhibition accounts <br />                                           relative lack efficacy drugs Leishmania (Bello et al., 1994, Nare et <br />                                           al., 1997). <br />  <br />                                           While folate metabolizing enzymes essential Leishmania (DHFR-TS, <br />                                           folylpolyglutamyl-synthase) (Cruz &amp; Beverley, 1990, El Fadili et al., 2002), tested <br />                                           appear largely wholly dispensable growth virulence, including methylene <br />                                           tetrahydrofolate reductase glycine cleavage complex (Scott et al., 2008, Vickers et <br />                                           al., 2006). This reflect ability parasite salvage sufficient quantities many <br />                                           C1-THF dependent metabolites amino acids purines (Carter et al., 2008, Scott et <br />                                           al., 1987), particularly mammalian stages parasite reside within <br />                                           phagolysosomes postulated rich free amino acids (McConville et al., 2007). <br />                                           In contrast, unable rescue requirement DHCH1 wide array of <br />                                           metabolites known postulated rescue DHCH deficiency. This reflect factors <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           including deficiency non-salvageable metabolite, conclusion consistent an <br />                                           essential requirement mitochondrial fMet-tRNAMet. <br />  <br />                                           For parasite enzyme good drug target essential parasite survival, <br />                                           dispensable, absent, substantially different host (Fairlamb, 2002). In mammals <br />                                           cystosolic mitochondrial forms DHCH (MTHFD1 MTHFD2 respectively) <br />                                           essential early development (Di Pietro et al., 2002, Brody et al., 2002, Parle-McDermott <br />                                           et al., 2005). However, human fibroblasts lacking enzyme viable, purine or <br />                                           glycine auxotrophs (Christensen et al., 2005b, Patel et al., 2003), 10-CHO-THF <br />                                           metabolism dispensable yeast S. cerevisiae grown rich media (West et al., <br />                                           1996). This suggests adult tissues human host dependent DHCH <br />                                           activity Leishmania. In contrast, 10-CHO-THF pathway simplified parasitic <br />                                           protozoans, species synthesize single cytosolic DHCH FTL (L. major, L. <br />                                           braziliensis), synthesize just cytosolic DHCH (African trypanosomes) (Vickers <br />                                           et al., 2008). Preliminary genomic analysis suggest like African trypanosomes, malaria <br />                                           parasite P. falciparum possess single route 10-CHO-THF synthesis, bifunctional <br />                                           DHCH (Nzila et al., 2005). These data suggest relative simplicity 10-CHO-THF <br />                                           pathway parasitic protozoa relative human host render sensitive to <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           chemotherapeutic interventions. <br />  <br />                                           While DHCH inhibitors developed, L. major DHCH1 activity promastigote <br />                                           growth vitro sensitive substrate analog 5,10-CO-THF (Temple et al., 1982). The <br />                                           specificity inhibitor supported findings DHCH1 overexpressors less <br />                                           susceptible, fails inhibit DHFR FTL enzymatic activity. However, over-expression <br />                                           FTL did completely overcome 5,10-CO-THF inhibition suggesting other <br />                                           targets DHCH1. <br />  <br />                                           Consistent genetic studies above, DHCH inhibitors little activity toxicity <br />                                           mammalian cells vitro, mouse cancer models, concentrations 10 &#206;&#188;M <br />                                           (Tonkinson et al., 1998, Temple et al., 1982). In preliminary studies modest activity <br />                                           5,10-CO-THF Leishmania amastigotes macrophages (EC50 ~ 5 &#206;&#188;M), although <br />                                           host cell toxicity seen 10 &#206;&#188;M (S. Hickerson S. Beverley, unpublished data). <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                              Page 11 <br />  <br />  <br />                                           These results encouraging 5,10-CO-THF actually selective host than <br />                                           parasite enzymes (Ki = 18 v. 105 nM respectively; (Schmidt et al., 2000) Fig. 6). While highly <br />                                           conserved, numerous differences Leishmania DHCH1 human cytosolic and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           mitochondrial DHCHs (Fig. S2) exploited design selective potent <br />                                           inhibitors. DHCH inhibitors received high priority cancer chemotherapy programs <br />                                           poor efficacy ones tested, number antifolates targeting 10- <br />                                           CHO-THF utilizing enzymes GAR transformylase developed (Zhang et <br />                                           al., 2003). Possibly, similar pharmacophores hold promise targeting 10-CHO-THF <br />                                           metabolism Leishmania Trypanosomatids. <br />  <br />                               EXPERIMENTAL PROCEDURES <br />                               Reagents <br />                                           (6-R,S)-Tetrahydrofolate (THF) 5,10-CH=THF obtained Schircks Laboratories <br />                                           (Jona, Switzerland). (2S)-2-[[4-[(6aR)-3-amino-1,9-dioxo-5,6,6a,7-tetrahydro-4H- imidazo <br />                                           [3,4-f]pteridin-8-yl]benzoyl]amino]pentanedioic acid (5,10-CO-THF) custom <br />                                           synthesized SAFC Pharma, division Sigma-Aldrich Corporation, according the <br />                                           method Temple et al. (Temple et al., 1982); compound 96.2% pure high- <br />                                           performance liquid chromatography. Methotrexate compound 25 (2,4-Diamino-6,7- <br />                                           diisopropylpteridine) purchased Sigma, folate analogues compound 34 (2,4- <br />                                           diamino-6-(3,4-dichlorophenoxy)-quinazoline) compound 70 (2,4-diamino-6-benzyl-5- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           (3-phenylpropyl)-pyrimidine) described (Hardy et al., 1997). Hygromycin B (HYG) <br />                                           purchased Calbiochem (EMD Biosciences, San Diego, CA) nourseothricin <br />                                           (SAT) Werner BioAgents (Jena, Germany). All chemicals reagents were <br />                                           analytical grade purchased Sigma-Aldrich. <br />  <br />                               Parasite growth drug inhibition <br />                                           All studies used derivatives L. major clone Friedlin V1 promastigotes, grown 27&#194;&#176;C in <br />                                           M199 medium (US Biologicals) supplemented 40 mM 4-(2-hydroxyethyl)-1- <br />                                           piperazineethanesulfonic acid (HEPES) pH 7.4, 50 &#206;&#188;M adenosine, 1 &#206;&#188;g ml&#226;&#710;&#8217;1 biotin, 5 &#206;&#188;g <br />                                           ml&#226;&#710;&#8217;1 hemin, 2 &#206;&#188;g ml&#226;&#710;&#8217;1 biopterin 10 % (v/v) heat-inactivated fetal calf serum. Growth was <br />                                           determined seeding parasites 5 &#195;&#8212; 105 cells ml&#226;&#710;&#8217;1 various concentrations drug and <br />                                           counting cells using model Z1 Coulter counter cultures reached late-log phase. The <br />                                           EC50 value concentration drug required decrease growth 50%. <br />  <br />                                           Cloning L. major DHCH1&#226;&#8364;&#8221;The DHCH1 coding sequence amplified with <br />                                           recombinant Pfu DNA polymerase (Stratagene) using L. major genomic DNA template, <br />                                           prepared LiCl mini-prep method (Medina-Acosta &amp; Cross, 1993), using primers <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           SMB3528 SMB3529, added 5&#226;&#8364;&#178; NdeI 3&#226;&#8364;&#178; BamHI sites, respectively. The amplified <br />                                           product cloned pCR.blunt (Invitrogen), yielding pCR.blunt. DHCH1 (B6255) the <br />                                           NdeI-BamHI fragment transferred corresponding sites pET15b (Novagen), yielding <br />                                           pET15b-LmjDHCH1 (B6026). <br />  <br />                               Expression, purification enzymatic assays recombinant L. major DHCH1 <br />                                           Protein expressed E. coli pET15b-LmjDHCH1 purified metal-affinity <br />                                           chromatography, described supplemental methods. During purification storage <br />                                           protein inclusion 10% glycerol buffers required prevent loss of <br />                                           activity. In manner, enzyme flash-frozen loss activity. DHCH <br />                                           activities measured spectrophotometrically, using temperature-controlled Beckman <br />                                           DU-640 spectrophotometer, essentially described Tan et al. (Tan et al., 1977) following <br />                                           formation 5,10-CH=THF 5,10-CH2-THF (DH activity) conversion of <br />                                           5,10-CH=THF 10-CHO-THF (CH activity). 5,10-CH2-THF dehydrogenase assays were <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                           Page 12 <br />  <br />  <br />                                           carried 0.5 ml volume 27&#194;&#176;C contained 25 mM MOPS, pH 7.3, 250 &#206;&#188;M THF, <br />                                           2.5 mM formaldehyde, 1 mM NADP+ 30 mM 2-mercaptoethanol. Assays were <br />                                           preincubated 5 min allow formation 5,10-CH2-THF reactions initiated the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           addition enzyme. The reactions stopped 5 min addition equal <br />                                           volume 1 M HCl 5,10-CH=THF produced quantified 350 nm, using extinction <br />                                           coefficient 24.9 mM&#226;&#710;&#8217;1 cm&#226;&#710;&#8217;1. DH activity expressed &#206;&#188;moles 5,10-CH=THF produced <br />                                           minute. Formaldehyde stocks freshly-prepared paraformaldehyde, THF <br />                                           dissolved just use 250 mM triethanolamine-Cl, pH 7, 40 mM 2-mercaptoethanol. <br />                                           Cyclohydrolase activity measured 0.5 ml assays 27&#194;&#176;C containing 25 mM MOPS, pH <br />                                           7.3, 30 mM 2-mercaptoethanol 50 &#206;&#188;M 5, 10-CH=THF. The hydrolysis 5,10-CH=THF <br />                                           followed 355 nm, non-enzymatic rate subtracted. <br />  <br />                                           Enzyme inhibition measured using dehydrogenase assay, stocks hydrophobic <br />                                           diaminoquinazolines diaminopteridines dissolved DMSO, 5,10-CO-THF dissolved <br />                                           250 mM triethanolamine-Cl, pH 7, 40 mM 2-mercaptoethanol, THF, stored at <br />                                           &#226;&#710;&#8217;80 &#194;&#176;C. 5,10-CO-THF custom synthesized Sigma-Aldrich Chemical Pvt. Ltd. <br />                                           (Bangalore, India); authenticity procuct supported infrared spectroscopy and <br />                                           proton NMR estimated greater 96% pure. Data 5,10-CO-THF <br />                                           inhibition assays fitted competitive, non-competitive, uncompetitive mixed <br />                                           inhibition models non-linear regression using Sigmaplot. The DHFR activity the <br />                                           bifunctional L. major DHFR-TS measured described (Hardy et al., 1997). Activity in <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           drug assays expressed percentage no-drug DMSO control. <br />  <br />                               DHCH1 replacement constructs <br />                                           Fusion PCR (Szewczyk et al., 2006) used generate deletion constructs, which <br />                                           contained puromycin (PAC) hygromycin (HYG) drug-resistance cassettes between <br />                                           5&#226;&#8364;&#178; 3&#226;&#8364;&#178; LmjDHCH1 flanking sequences (Szewczyk et al., 2006). Briefly, flanking <br />                                           sequences drug resistance cassettes amplified separately PCR using primers that <br />                                           produce overlapping ends. The 5&#226;&#8364;&#178; 3&#226;&#8364;&#178; LmjDHCH1 flanking sequences (743 726 bp), <br />                                           amplified using primers SMB2772/2656 2657/2773 added SphI and <br />                                           BamHI site, respectively. PAC HYG drug-resistance cassettes (600 1026 bp) were <br />                                           amplified using primers SMB2557/2558 SMB2561/2562, respectively added a <br />                                           linker sequence. Each deletion construct mixing purified PCR products <br />                                           flanking sequences drug-resistance cassette using products templates <br />                                           second round PCR. The PCR reactions generate PAC HYG constructs <br />                                           used external primers SMB2772 2773, fused flanking sequences the <br />                                           correct drug resistance cassette. These deletion constructs cloned pGEM- <br />                                           T (Promega), yielding pGEM-T.5&#226;&#8364;&#178;. PAC.3&#226;&#8364;&#178;. LmjDHCH1 (B4827) pGEM-T.5&#226;&#8364;&#178;. HYG.3&#226;&#8364;&#178;. <br />                                           LmjDHCH1 (B4827). The sequences constructs confirmed restriction <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           mapping sequencing. <br />  <br />                               DHCH1 replacement transfections <br />                                           DHCH1-targeting fragments digested SphI BamHI, linear targeting <br />                                           fragments containing PAC (2.1 kb) HYG (2.5 kb) transfected separately wild-type <br />                                           (WT) L. major FV1 promastigotes described (Robinson &amp; Beverley, 2003). Heterozygous <br />                                           clones, DHCH1/&#206;&#8221;dhch1::PAC DHCH1/&#206;&#8221;dhch1::HYG (referred PAC/+ HYG/+), were <br />                                           isolated plating semisolid M199 medium containing 30 &#206;&#188;g ml&#226;&#710;&#8217;1 puromycin 50 &#206;&#188;g <br />                                           ml&#226;&#710;&#8217;1 hygromycin B, respectively. Heterozygous PAC/+ HYG/+ clones transfected <br />                                           deletion constructs containing HYG PAC cassettes. The parasites plated in <br />                                           semisolid M199 medium containing 30 &#206;&#188;g ml&#226;&#710;&#8217;1 puromycin 50 &#206;&#188;g ml&#226;&#710;&#8217;1 hygromycin. In <br />                                           attempts rescue growth DHCH1&#226;&#710;&#8217;/&#226;&#710;&#8217; homozygotes different mixtures of <br />                                           different supplements added plating medium. The basic supplements were: glycine <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                                Page 13 <br />  <br />  <br />                                            (1 mg ml&#226;&#710;&#8217;1), serine (0.1 mg ml&#226;&#710;&#8217;1), formate (5 mM), THF (5 &#206;&#188;M), thymidine (10 &#206;&#188;g ml&#226;&#710;&#8217;1) and <br />                                            folinic acid (10 &#206;&#188;g ml&#226;&#710;&#8217;1). Additional supplements added basic mixture other <br />                                            plates, were: 5,10-CH=THF (10 &#206;&#188;M), 10-formylfolic acid 10-CHOFA (10 &#206;&#188;M) or, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            alternatively, uridine (0.1 mg ml&#226;&#710;&#8217;1) sodium pyruvate (1 mM). DNA contents of <br />                                            permeabilized RNAse treated cells measured propidium iodide staining using flow <br />                                            cytometry (Cruz et al., 1993). <br />  <br />                               PCR primers assessing chromosomal DHCH1 PAC HYG replacements <br />                                            Generation planned PAC HYG replacements confirmed PCR, using primer <br />                                            located 5&#226;&#8364;&#178; (SMB2731) 3&#226;&#8364;&#178; (SMB2771) DHCH1 ORF targeting fragment primer <br />                                            located PAC HYG genes (SMB2557/2558 SMB2561/2562). The loss the <br />                                            DHCH1 ORFs confirmed using primers specific chromosomal DHCH1 allele <br />                                            (SMB3125/3126) using forward primer located chromosome 5&#226;&#8364;&#178; (SBM2731) the <br />                                            DHCH1 ORF targeting fragment reverse primer located DHCH1 gene <br />                                            (SMB3126). <br />  <br />                               pXNG4 expression constructs <br />                                            DHCH1 FTL ORFs amplified primers (SMB3125/3126 SMB3123/3124, <br />                                            respectively) L. major genomic DNA, adding flanking BglII sites, CCACC sequence <br />                                            preceding initiation codon. The DHCH1 FTL ORFs inserted pGEM-T <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            (Promega) yielding pGEM-DHCH1 (B6029) pGEM-FTL (B6030); DHCH1 and <br />                                            FTL ORFs extracted BglII digestion inserted BglII site pXNG4 <br />                                            (B5840) create pXNG4-DHCH1 (B6031) pXNG4-FTL (B6032). <br />  <br />                                            These plasmids transfected wild-type L. major FV1, heterozygote lines <br />                                            (DHCH1/&#206;&#8221;dhch1::PAC DHCH1/&#206;&#8221; dhch1:: HYG) transformants isolated before, <br />                                            using plating media containing 100 &#206;&#188;g ml&#226;&#710;&#8217;1 nourseothricin 30 &#206;&#188;g ml&#226;&#710;&#8217;1 puromycin <br />                                            50 &#206;&#188;g ml&#226;&#710;&#8217;1 hygromycin. The presence plasmid confirmed PCR FACS analysis <br />                                            presence SAT GFP markers, respectively. Three colonies over-expressing FTL <br />                                            DHCH1 submitted second replacement using PAC HYG targeting <br />                                            fragments. The parasites isolated plating semi-solid M199 media containing 100 <br />                                            &#206;&#188;g ml&#226;&#710;&#8217;1 nourseothricin, 30 &#206;&#188;g ml&#226;&#710;&#8217;1 puromycin 50 &#206;&#188;g ml&#226;&#710;&#8217;1 hygromycin. <br />  <br />                               Single-cell sorting <br />                                            Prior flow cytometry, dhch1&#226;&#710;&#8217;/pXNG4-DHCH1 lines incubated 50 &#206;&#188;g ml&#226;&#710;&#8217;1 <br />                                            ganciclovir M199 media 24 h. Single cells sorting performed based their <br />                                            GFP fluorescence described Results. Cells resuspended phosphate-buffered <br />                                            saline, filtered CellTrics 50 &#206;&#188;m filters remove clumps (Partec). Single cells <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            recovered using Dako MoFlo high-speed cell sorter placed individual <br />                                            wells 96-well plates, containing 150 &#206;&#188;l M199 medium. Plates incubated 27&#194;&#176; C <br />                                            1&#226;&#8364;&#8220;2 weeks parasite growth scored. <br />  <br />                               Supplementary Material <br />                                            Refer Web version PubMed Central supplementary material. <br />  <br />  <br />                               Acknowledgments <br />                                            We thank A. Hanson M. Ouellette discussions. We thank Sushil Rajan Sigma-Aldrich Chemical Pvt. Ltd. <br />                                            custom synthesis 5,10-CO-THF. Single-cell sorting assistance staff high-speed <br />                                            sorter core, Alvin J. Siteman Cancer Center, Washington University Medical School. The Siteman Cancer Center is <br />                                            supported NCI Cancer Center Support Grant #P30 CA91842. This work supported National Institutes <br />  <br />  <br />  <br />  <br />                                                  Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                      Page 14 <br />  <br />                                           Health Grant AI21903 (to S.M.B.); Brazilian agencies: CNPq FAPEMIG (to S.M.F.M.) European <br />                                           Molecular Biology Organization long term fellowship ALTF 106&#226;&#8364;&#8220;2005 (to T. V.). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Abbreviations <br />                                           THF <br />                                                          tetrahydrofolate <br />  <br />                                           10-CHO-THF <br />                                                    10-formyl tetrahydrofolate <br />  <br />                                           5,10-CH=THF <br />                                                     5,10-methenyl-tetrahydrofolate <br />  <br />                                           5,10-CH2-THF <br />                                                      5,10-methylene-tetrahydrofolate <br />  <br />                                           DHCH1 <br />                                                          gene encoding Leishmania cytosolic methenyltetrahydrofolate cyclohydrolase/ <br />                                                          5,10-methylenetetrahydrofolate dehydrogenase <br />  <br />                                           FTL <br />                                                          formate-tetrahydrofolate ligase <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           DHFR-TS <br />                                                          dihydrofolate reductase-thymidylate synthase <br />  <br />                                           WT <br />                                                          wild-type <br />  <br />                                           DH <br />                                                          dehydrogenase <br />  <br />                                           CH <br />                                                          cyclohydrolase <br />  <br />                               References <br />                                           Allaire M, Li Y, MacKenzie RE, Cygler M. The 3-D structure folate-dependent dehydrogenase/ <br />                                             cyclohydrolase bifunctional enzyme 1.5 A resolution. Structure 1998;6:173&#226;&#8364;&#8220;182. [PubMed: <br />                                             9519408] <br />                                           Appling DR. Compartmentation folate-mediated one-carbon metabolism eukaryotes. Faseb J <br />                                             1991;5:2645&#226;&#8364;&#8220;2651. [PubMed: 1916088] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Balana-Fouce R, Garcia-Estrada C, Perez-Pertejo Y, Reguera RM. Gene disruption DNA <br />                                             topoisomerase IB small subunit induces non-viable phenotype hemoflagellate Leishmania <br />                                             major. BMC Microbiol 2008;8:113. [PubMed: 18611247] <br />                                           Barrett MP, Mottram JC, Coombs GH. Recent advances identifying validating drug targets in <br />                                             trypanosomes leishmanias. Trends Microbiol 1999;7:82&#226;&#8364;&#8220;88. [PubMed: 10081086] <br />                                           Bello AR, Nare B, Freedman D, Hardy L, Beverley SM. PTR1: reductase mediating salvage oxidized <br />                                             pteridines methotrexate resistance protozoan parasite Leishmania major. Proc Natl Acad <br />                                             Sci U S A 1994;91:11442&#226;&#8364;&#8220;11446. [PubMed: 7972081] <br />                                           Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, Bartholomeu DC, Lennard NJ, Caler E, <br />                                             Hamlin NE, Haas B, Bohme U, Hannick L, Aslett MA, Shallom J, Marcello L, Hou L, Wickstead B, <br />                                             Alsmark UC, Arrowsmith C, Atkin RJ, Barron AJ, Bringaud F, Brooks K, Carrington M, Cherevach <br />                                             I, Chillingworth TJ, Churcher C, Clark LN, Corton CH, Cronin A, Davies RM, Doggett J, Djikeng A, <br />                                             Feldblyum T, Field MC, Fraser A, Goodhead I, Hance Z, Harper D, Harris BR, Hauser H, Hostetler <br />                                             J, Ivens A, Jagels K, Johnson D, Johnson J, Jones K, Kerhornou AX, Koo H, Larke N, Landfear S, <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                    Page 15 <br />  <br />  <br />                                             Larkin C, Leech V, Line A, Lord A, Macleod A, Mooney PJ, Moule S, Martin DM, Morgan GW, <br />                                             Mungall K, Norbertczak H, Ormond D, Pai G, Peacock CS, Peterson J, Quail MA, Rabbinowitsch E, <br />                                             Rajandream MA, Reitter C, Salzberg SL, Sanders M, Schobel S, Sharp S, Simmonds M, Simpson AJ, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Tallon L, Turner CM, Tait A, Tivey AR, Van Aken S, Walker D, Wanless D, Wang S, White B, White <br />                                             O, Whitehead S, Woodward J, Wortman J, Adams MD, Embley TM, Gull K, Ullu E, Barry JD, <br />                                             Fairlamb AH, Opperdoes F, Barrell BG, Donelson JE, Hall N, Fraser CM, et al. The genome the <br />                                             African trypanosome Trypanosoma brucei. Science 2005;309:416&#226;&#8364;&#8220;422. [PubMed: 16020726] <br />                                           Beverley SM. Protozomics: trypanosomatid parasite genetics comes age. Nat Rev Genet 2003;4:11&#226;&#8364;&#8220; <br />                                             19. [PubMed: 12509749] <br />                                           Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy AM, O&#226;&#8364;&#8482;Leary VB, Parle- <br />                                             McDermott A, Scott JM, Swanson DA. A polymorphism, R653Q, trifunctional enzyme <br />                                             methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/ <br />                                             formyltetrahydrofolate synthetase maternal genetic risk factor neural tube defects: report of <br />                                             Birth Defects Research Group. Am J Hum Genet 2002;71:1207&#226;&#8364;&#8220;1215. [PubMed: 12384833] <br />                                           Brouwer VD, Zhang GF, Storozhenko S, Straeten DV, Lambert WE. pH stability individual folates <br />                                             critical sample preparation steps prevision analysis plant folates. Phytochem Anal <br />                                             2007;18:496&#226;&#8364;&#8220;508. [PubMed: 17624887] <br />                                           Carter NS, Yates P, Arendt CS, Boitz JM, Ullman B. Purine pyrimidine metabolism in <br />                                               Leishmania. Adv Exp Med Biol 2008;625:141&#226;&#8364;&#8220;154. [PubMed: 18365665] <br />                                           Cavazzuti A, Paglietti G, Hunter WN, Gamarro F, Piras S, Loriga M, Allecca S, Corona P, McLuskey <br />                                               K, Tulloch L, Gibellini F, Ferrari S, Costi MP. Discovery potent pteridine reductase inhibitors to <br />                                               guide antiparasite drug development. Proc Natl Acad Sci U S A 2008;105:1448&#226;&#8364;&#8220;1453. [PubMed: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               18245389] <br />                                           Charriere F, Tan TH, Schneider A. Mitochondrial initiation factor 2 Trypanosoma brucei binds <br />                                               imported formylated elongator-type tRNA(Met). J Biol Chem 2005;280:15659&#226;&#8364;&#8220;15665. [PubMed: <br />                                               15731104] <br />                                           Christensen KE, MacKenzie RE. Mitochondrial one-carbon metabolism adapted specific needs <br />                                               yeast, plants mammals. Bioessays 2006;28:595&#226;&#8364;&#8220;605. [PubMed: 16700064] <br />                                           Christensen KE, Mackenzie RE. Chapter 14. Mitochondrial methylenetetrahydrofolate dehydrogenase, <br />                                               methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetases. Vitam Horm <br />                                               2008;79:393&#226;&#8364;&#8220;410. [PubMed: 18804703] <br />                                           Christensen KE I, Mirza A, Berghuis AM, Mackenzie RE. Magnesium phosphate ions enable NAD <br />                                               binding methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase. J <br />                                               Biol Chem 2005a;280:34316&#226;&#8364;&#8220;34323. [PubMed: 16100107] <br />                                           Christensen KE, Patel H, Kuzmanov U, Mejia NR, MacKenzie RE. Disruption mthfd1 gene reveals <br />                                               monofunctional 10-formyltetrahydrofolate synthetase mammalian mitochondria. J Biol Chem <br />                                               2005b;280:7597&#226;&#8364;&#8220;7602. [PubMed: 15611115] <br />                                           Clayton CE. Genetic manipulation kinetoplastida. Parasitol Today 1999;15:372&#226;&#8364;&#8220;378. [PubMed: <br />                                               10461166] <br />                                           Coderre JA, Beverley SM, Schimke RT, Santi DV. Overproduction bifunctional thymidylate <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               synthetase-dihydrofolate reductase DNA amplification methotrexate-resistant Leishmania <br />                                               tropica. Proc Natl Acad Sci U S A 1983;80:2132&#226;&#8364;&#8220;2136. [PubMed: 6572966] <br />                                           Cruz A, Beverley SM. Gene replacement parasitic protozoa. Nature 1990;348:171&#226;&#8364;&#8220;173. [PubMed: <br />                                               2234081] <br />                                           Cruz A, Coburn C, Beverley SM. Double targeted gene replacement creating null mutants. <br />                                               Proceedings National Academy Sciences 1991;88:7170&#226;&#8364;&#8220;7174. <br />                                           Cruz AK, Titus R, Beverley SM. Plasticity chromosome number testing essential genes in <br />                                               Leishmania targeting. Proc Natl Acad Sci U S A 1993;90:1599&#226;&#8364;&#8220;1603. [PubMed: 8381972] <br />                                           Di Pietro E, Sirois J, Tremblay ML, MacKenzie RE. Mitochondrial NAD-dependent <br />                                               methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase essential for <br />                                               embryonic development. Mol Cell Biol 2002;22:4158&#226;&#8364;&#8220;4166. [PubMed: 12024029] <br />                                           Dumas C, Ouellette M, Tovar J, Cunningham ML, Fairlamb AH, Tamar S, Olivier M, Papadopoulou B. <br />                                               Disruption trypanothione reductase gene Leishmania decreases ability survive <br />                                               oxidative stress macrophages. EMBO J 1997;16:2590&#226;&#8364;&#8220;2598. [PubMed: 9184206] <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                  Page 16 <br />  <br />  <br />                                           El-Sayed NM, Myler PJ, Blandin G, Berriman M, Crabtree J, Aggarwal G, Caler E, Renauld H, Worthey <br />                                               EA, Hertz-Fowler C, Ghedin E, Peacock C, Bartholomeu DC, Haas BJ, Tran AN, Wortman JR, <br />                                               Alsmark UC, Angiuoli S, Anupama A, Badger J, Bringaud F, Cadag E, Carlton JM, Cerqueira GC, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Creasy T, Delcher AL, Djikeng A, Embley TM, Hauser C, Ivens AC, Kummerfeld SK, Pereira-Leal <br />                                               JB, Nilsson D, Peterson J, Salzberg SL, Shallom J, Silva JC, Sundaram J, Westenberger S, White O, <br />                                               Melville SE, Donelson JE, Andersson B, Stuart KD, Hall N. Comparative genomics of <br />                                               trypanosomatid parasitic protozoa. Science 2005;309:404&#226;&#8364;&#8220;409. [PubMed: 16020724] <br />                                           El Fadili A, Kundig C, Ouellette M. Characterization folylpolyglutamate synthetase gene and <br />                                               polyglutamylation folates protozoan parasite Leishmania. Mol Biochem Parasitol <br />                                               2002;124:63&#226;&#8364;&#8220;71. [PubMed: 12387851] <br />                                           Fairlamb AH. Metabolic pathway analysis trypanosomes malaria parasites. Philos Trans R Soc <br />                                               Lond B Biol Sci 2002;357:101&#226;&#8364;&#8220;107. [PubMed: 11839187] <br />                                           Forsburg SL. The art design genetic screens: yeast. Nat Rev Genet 2001;2:659&#226;&#8364;&#8220;668. [PubMed: <br />                                               11533715] <br />                                           Hanson AD, Gage DA, Shachar-Hill Y. Plant one-carbon metabolism engineering. Trends Plant <br />                                               Sci 2000;5:206&#226;&#8364;&#8220;213. [PubMed: 10785666] <br />                                           Hanson AD, Roje S. One-Carbon Metabolism Higher Plants. Annu Rev Plant Physiol Plant Mol Biol <br />                                               2001;52:119&#226;&#8364;&#8220;137. [PubMed: 11337394] <br />                                           Hardy LW, Matthews W, Nare B, Beverley SM. Biochemical genetic tests inhibitors of <br />                                               Leishmania pteridine pathways. Exp Parasitol 1997;87:157&#226;&#8364;&#8220;169. [PubMed: 9371081] <br />                                           Hatefi Y, Osborn MJ, Kay LD, Huennekens FM. Hydroxymethyl tetrahydrofolic dehydrogenase. J Biol <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Chem 1957;227:637&#226;&#8364;&#8220;647. [PubMed: 13462986] <br />                                           Ilgoutz SC, Mullin KA, Southwell BR, McConville MJ. Glycosylphosphatidylinositol biosynthetic <br />                                               enzymes localized stable tubular subcompartment endoplasmic reticulum in <br />                                               Leishmania mexicana. EMBO J 1999a;18:3643&#226;&#8364;&#8220;3654. [PubMed: 10393180] <br />                                           Ilgoutz SC, Zawadzki JL, Ralton JE, McConville MJ. Evidence free GPI glycolipids essential <br />                                               growth Leishmania mexicana. EMBO J 1999b;18:2746&#226;&#8364;&#8220;2755. [PubMed: 10329621] <br />                                           Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, Sisk E, Rajandream MA, <br />                                               Adlem E, Aert R, Anupama A, Apostolou Z, Attipoe P, Bason N, Bauser C, Beck A, Beverley SM, <br />                                               Bianchettin G, Borzym K, Bothe G, Bruschi CV, Collins M, Cadag E, Ciarloni L, Clayton C, Coulson <br />                                               RM, Cronin A, Cruz AK, Davies RM, De Gaudenzi J, Dobson DE, Duesterhoeft A, Fazelina G, <br />                                               Fosker N, Frasch AC, Fraser A, Fuchs M, Gabel C, Goble A, Goffeau A, Harris D, Hertz-Fowler C, <br />                                               Hilbert H, Horn D, Huang Y, Klages S, Knights A, Kube M, Larke N, Litvin L, Lord A, Louie T, <br />                                               Marra M, Masuy D, Matthews K, Michaeli S, Mottram JC, Muller-Auer S, Munden H, Nelson S, <br />                                               Norbertczak H, Oliver K, O&#226;&#8364;&#8482;Neil S, Pentony M, Pohl TM, Price C, Purnelle B, Quail MA, <br />                                               Rabbinowitsch E, Reinhardt R, Rieger M, Rinta J, Robben J, Robertson L, Ruiz JC, Rutter S, Saunders <br />                                               D, Schafer M, Schein J, Schwartz DC, Seeger K, Seyler A, Sharp S, Shin H, Sivam D, Squares R, <br />                                               Squares S, Tosato V, Vogt C, Volckaert G, Wambutt R, Warren T, Wedler H, Woodward J, Zhou S, <br />                                               Zimmermann W, Smith DF, Blackwell JM, Stuart KD, Barrell B, et al. The genome the <br />                                               kinetoplastid parasite, Leishmania major. Science 2005;309:436&#226;&#8364;&#8220;442. [PubMed: 16020728] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Kedzierski L, Zhu Y, Handman E. Leishmania vaccines: progress problems. Parasitology 2006;133 <br />                                               (Suppl):S87&#226;&#8364;&#8220;112. [PubMed: 17274851] <br />                                           Kozak M. Comparison initiation protein synthesis procaryotes, eucaryotes, organelles. <br />                                               Microbiol Rev 1983;47:1&#226;&#8364;&#8220;45. [PubMed: 6343825] <br />                                           Li Y, Holmes WB, Appling DR, RajBhandary UL. Initiation protein synthesis Saccharomyces <br />                                               cerevisiae mitochondria formylation initiator tRNA. J Bacteriol 2000;182:2886&#226;&#8364;&#8220;2892. <br />                                               [PubMed: 10781559] <br />                                           McConville MJ, Souza D, Saunders E, Likic VA, Naderer T. Living phagolysosome; metabolism <br />                                               Leishmania amastigotes. Trends Parasitol 2007;23:368&#226;&#8364;&#8220;375. [PubMed: 17606406] <br />                                           Medina-Acosta E, Cross GA. Rapid isolation DNA trypanosomatid protozoa using simple <br />                                               &#226;&#8364;&#732;mini-prep&#226;&#8364;&#8482; procedure. Mol Biochem Parasitol 1993;59:327&#226;&#8364;&#8220;329. [PubMed: 8341329] <br />                                           Mejia NR, MacKenzie RE. NAD-dependent methylenetetrahydrofolate dehydrogenase- <br />                                               methenyltetrahydrofolate cyclohydrolase transformed cells mitochondrial enzyme. Biochem <br />                                               Biophys Res Commun 1988;155:1&#226;&#8364;&#8220;6. [PubMed: 3261979] <br />  <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                   Page 17 <br />  <br />  <br />                                           Mishra J, Saxena A, Singh S. Chemotherapy leishmaniasis: past, present future. Curr Med Chem <br />                                               2007;14:1153&#226;&#8364;&#8220;1169. [PubMed: 17456028] <br />                                           Moore MR, O&#226;&#8364;&#8482;Brien WE, Ljungdahl LG. Purification characterization nicotinamide adenine <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               dinucleotide-dependent methylenetetrahydrofolate dehydrogenase Clostridium <br />                                               formicoaceticum. J Biol Chem 1974;249:5250&#226;&#8364;&#8220;5253. [PubMed: 4153026] <br />                                           Nare B, Luba J, Hardy LW, Beverley S. New approaches Leishmania chemotherapy: pteridine <br />                                               reductase 1 (PTR1) target modulator antifolate sensitivity. Parasitology 1997;114:S101&#226;&#8364;&#8220; <br />                                               110. [PubMed: 9309772] <br />                                           Newton DT, Creuzenet C, Mangroo D. Formylation essential initiation protein synthesis in <br />                                               eubacteria. J Biol Chem 1999;274:22143&#226;&#8364;&#8220;22146. [PubMed: 10428776] <br />                                           Nour JM, Rabinowitz JC. Isolation, characterization, structural organization 10- <br />                                               formyltetrahydrofolate synthetase spinach leaves. J Biol Chem 1991;266:18363&#226;&#8364;&#8220;18369. <br />                                               [PubMed: 1917961] <br />                                           Nzila A, Ward SA, Marsh K, Sims PF, Hyde JE. Comparative folate metabolism humans malaria <br />                                               parasites (part I): pointers malaria treatment cancer chemotherapy. Trends Parasitol <br />                                               2005;21:292&#226;&#8364;&#8220;298. [PubMed: 15922251] <br />                                           Opperdoes FR, Coombs GH. Metabolism Leishmania: proven predicted. Trends Parasitol <br />                                               2007;23:149&#226;&#8364;&#8220;158. [PubMed: 17320480] <br />                                           Ouellette M, Drummelsmith J, El-Fadili A, Kundig C, Richard D, Roy G. Pterin transport metabolism <br />                                               Leishmania related trypanosomatid parasites. Int J Parasitol 2002;32:385&#226;&#8364;&#8220;398. [PubMed: <br />                                               11849635] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Papadopoulou B, Dumas C. Parameters controlling rate gene targeting frequency protozoan <br />                                               parasite Leishmania. Nucleic Acids Res 1997;25:4278&#226;&#8364;&#8220;4286. [PubMed: 9336458] <br />                                           Parle-McDermott A, Pangilinan F, Mills JL, Signore CC, Molloy AM, Cotter A, Conley M, Cox C, Kirke <br />                                               PN, Scott JM, Brody LC. A polymorphism MTHFD1 gene increases mother&#226;&#8364;&#8482;s risk having <br />                                               unexplained second trimester pregnancy loss. Mol Hum Reprod 2005;11:477&#226;&#8364;&#8220;480. [PubMed: <br />                                               16123074] <br />                                           Patel H, Pietro ED, MacKenzie RE. Mammalian fibroblasts lacking mitochondrial NAD+-dependent <br />                                               methylenetetrahydrofolate dehydrogenase-cyclohydrolase glycine auxotrophs. J Biol Chem <br />                                               2003;278:19436&#226;&#8364;&#8220;19441. [PubMed: 12646567] <br />                                           Pawelek PD, MacKenzie RE. Methenyltetrahydrofolate cyclohydrolase rate limiting enzymatic <br />                                               conversion 10-formyltetrahydrofolate 5,10-methylenetetrahydrofolate bifunctional <br />                                               dehydrogenase-cyclohydrolase enzymes. Biochemistry 1998;37:1109&#226;&#8364;&#8220;1115. [PubMed: 9454603] <br />                                           Peacock CS, Seeger K, Harris D, Murphy L, Ruiz JC, Quail MA, Peters N, Adlem E, Tivey A, Aslett M, <br />                                               Kerhornou A, Ivens A, Fraser A, Rajandream MA, Carver T, Norbertczak H, Chillingworth T, Hance <br />                                               Z, Jagels K, Moule S, Ormond D, Rutter S, Squares R, Whitehead S, Rabbinowitsch E, Arrowsmith <br />                                               C, White B, Thurston S, Bringaud F, Baldauf SL, Faulconbridge A, Jeffares D, Depledge DP, Oyola <br />                                               SO, Hilley JD, Brito LO, Tosi LR, Barrell B, Cruz AK, Mottram JC, Smith DF, Berriman M. <br />                                               Comparative genomic analysis Leishmania species cause diverse human disease. Nat <br />                                               Genet 2007;39:839&#226;&#8364;&#8220;847. [PubMed: 17572675] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Prabhu V, Chatson KB, Lui H, Abrams GD, King J. Effects sulfanilamide methotrexate 13C <br />                                               fluxes glycine decarboxylase/serine hydroxymethyltransferase enzyme in <br />                                               arabidopsis. Plant Physiol 1998;116:137&#226;&#8364;&#8220;144. [PubMed: 9449840] <br />                                           Rabinowitz JC. Preparation properties 5,10-methenyltetrahydrofolic acid 10- <br />                                               Formyltetrahydrofolic acid. Methods Enzymology 1963;6:814&#226;&#8364;&#8220;815. <br />                                           Rabinowitz JC, Pricer WE Jr. Formyltetrahydrofolate synthetase. I. Isolation crystallization the <br />                                               enzyme. J Biol Chem 1962;237:2898&#226;&#8364;&#8220;2902. [PubMed: 14489619] <br />                                           RajBhandary UL. Initiator transfer RNAs. J Bacteriol 1994;176:547&#226;&#8364;&#8220;552. [PubMed: 7507918] <br />                                           RajBhandary UL. More surprises translation: initiation initiator tRNA. Proc Natl Acad Sci <br />                                               U S A 2000;97:1325&#226;&#8364;&#8220;1327. [PubMed: 10677458] <br />                                           Robinson KA, Beverley SM. Improvements transfection efficiency tests <span id='am-315' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-316' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-317' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-318' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-319' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-320' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-321' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-322' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-323' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-324' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-325' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-326' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-327' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-328' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-329' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-330' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-331' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-332' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-333' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-334' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-335' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-336' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-337' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-338' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-339' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-340' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-341' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-342' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-343' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-344' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-345' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-346' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-347' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-348' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-349' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-350' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-351' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-352' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-353' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-354' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-355' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-356' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-357' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-358' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-359' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-360' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-361' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-362' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-363' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-364' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-365' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-366' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-367' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-368' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-369' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-371' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-372' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-373' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-374' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-375' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-376' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-377' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-378' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-379' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-380' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-381' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-382' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-383' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-384' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-385' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-386' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-387' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-388' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-389' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-390' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-391' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-392' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span>RNA interference</span> <br />                                               (RNAi) approaches protozoan parasite Leishmania. Mol Biochem Parasitol 2003;128:217&#226;&#8364;&#8220; <br />                                               228. [PubMed: 12742588] <br />  <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                     Page 18 <br />  <br />  <br />                                           Schmidt A, Wu H, MacKenzie RE, Chen VJ, Bewly JR, Ray JE, Toth JE, Cygler M. Structures three <br />                                               inhibitor complexes provide insight reaction mechanism human <br />                                               methylenetetrahydrofolate dehydrogenase/cyclohydrolase. Biochemistry 2000;39:6325&#226;&#8364;&#8220;6335. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               [PubMed: 10828945] <br />                                           Schweitzer BI, Dicker AP, Bertino JR. Dihydrofolate reductase therapeutic target. FASEB J <br />                                               1990;4:2441&#226;&#8364;&#8220;2452. [PubMed: 2185970] <br />                                           Scott DA, Coombs GH, Sanderson BE. Folate utilization Leishmania species identification <br />                                               intracellular derivatives folate-metabolizing enzymes. Mol Biochem Parasitol 1987;23:139&#226;&#8364;&#8220; <br />                                               149. [PubMed: 3574356] <br />                                           Scott DA, Hickerson SM, Vickers TJ, Beverley SM. The role mitochondrial glycine cleavage <br />                                               complex metabolism virulence protozoan parasite Leishmania major. J Biol Chem <br />                                               2008;283:155&#226;&#8364;&#8220;165. [PubMed: 17981801] <br />                                           Sen N, Banerjee B, Gupta SS, Das BB, Ganguly A, Majumder HK. Leishmania donovani: <br />                                               dyskinetoplastid cells survive proliferate presence pyruvate uridine not <br />                                               undergo apoptosis treatment camptothecin. Exp Parasitol 2007;115:215&#226;&#8364;&#8220;219. [PubMed: <br />                                               17027973] <br />                                           Spencer AC, Spremulli LL. Interaction mitochondrial initiation factor 2 mitochondrial fMet- <br />                                               tRNA. Nucleic Acids Res 2004;32:5464&#226;&#8364;&#8220;5470. [PubMed: 15477394] <br />                                           Stanger O. Physiology folic acid health disease. Curr Drug Metab 2002;3:211&#226;&#8364;&#8220;223. [PubMed: <br />                                               12003352] <br />                                           Szewczyk E, Nayak T, Oakley CE, Edgerton H, Xiong Y, Taheri-Talesh N, Osmani SA, Oakley BR. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Fusion PCR gene targeting Aspergillus nidulans. Nat Protoc 2006;1:3111&#226;&#8364;&#8220;3120. [PubMed: <br />                                               17406574] <br />                                           Tan LU, Drury EJ, MacKenzie RE. Methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate <br />                                               cyclohydrolase-formyltetrahydrofolate synthetase. A multifunctional protein porcine liver. J <br />                                               Biol Chem 1977;252:1117&#226;&#8364;&#8220;1122. [PubMed: 838698] <br />                                           Tan TH, Bochud-Allemann N, Horn EK, Schneider A. Eukaryotic-type elongator tRNAMet of <br />                                               Trypanosoma brucei formylated import mitochondria. Proc Natl Acad Sci U S A <br />                                               2002;99:1152&#226;&#8364;&#8220;1157. [PubMed: 11792845] <br />                                           Temple C Jr, Bennett LL Jr, Rose JD, Elliott RD, Montgomery JA, Mangum JH. Synthesis pseudo <br />                                               cofactor analogues potential inhibitors folate enzymes. J Med Chem 1982;25:161&#226;&#8364;&#8220;166. <br />                                               [PubMed: 7057422] <br />                                           Then RL. Antimicrobial dihydrofolate reductase inhibitors--achievements future options: review. J <br />                                               Chemother 2004;16:3&#226;&#8364;&#8220;12. [PubMed: 15077993] <br />                                           Tonkinson JL, Habeck LL, Toth JE, Mendelsohn LG, Bewley J, Shackelford KA, Gates SB, Ray J, Chen <br />                                               VJ. The antiproliferative cell cycle effects 5,6,7, 8-tetrahydro-N5, N10-carbonylfolic acid, an <br />                                               inhibitor methylenetetrahydrofolate dehydrogenase, potentiated hypoxanthine. J Pharmacol <br />                                               Exp Ther 1998;287:315&#226;&#8364;&#8220;321. [PubMed: 9765352] <br />                                           Varshney U, Lee CP, RajBhandary UL. From elongator tRNA initiator tRNA. Proc Natl Acad Sci U <br />                                               S A 1993;90:2305&#226;&#8364;&#8220;2309. [PubMed: 8460138] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Vergnes B, Sereno D, Tavares J, Cordeiro-da-Silva A, Vanhille L, Madjidian-Sereno N, Depoix D, <br />                                               Monte-Alegre A, Ouaissi A. Targeted disruption cytosolic SIR2 deacetylase discloses essential <br />                                               role Leishmania survival proliferation. Gene 2005;363:85&#226;&#8364;&#8220;96. [PubMed: 16236469] <br />                                           Vial L, Gomez P, Panvert M, Schmitt E, Blanquet S, Mechulam Y. Mitochondrial methionyl-tRNAfMet <br />                                               formyltransferase Saccharomyces cerevisiae: gene disruption tRNA substrate specificity. <br />                                               Biochemistry 2003;42:932&#226;&#8364;&#8220;939. [PubMed: 12549912] <br />                                           Vickers TJ, Murta SMF, Mandell MA, Beverley SM. 10-formyl-tetrahydrofolate synthesis exclusively <br />                                               cytosolic trypanosomatid parasite. Leishmania major. 2008(submitted) <br />                                           Vickers TJ, Orsomando G, la Garza RD, Scott DA, Kang SO, Hanson AD, Beverley SM. Biochemical <br />                                               genetic analysis methylenetetrahydrofolate reductase Leishmania metabolism and <br />                                               virulence. J Biol Chem 2006;281:38150&#226;&#8364;&#8220;38158. [PubMed: 17032644] <br />                                           Weber S. Light-driven enzymatic catalysis DNA repair: review recent biophysical studies on <br />                                               photolyase. Biochim Biophys Acta 2005;1707:1&#226;&#8364;&#8220;23. [PubMed: 15721603] <br />  <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                 Page 19 <br />  <br />  <br />                                           West MG, Horne DW, Appling DR. Metabolic role cytoplasmic isozymes 5,10- <br />                                              methylenetetrahydrofolate dehydrogenase Saccharomyces cerevisiae. Biochemistry <br />                                              1996;35:3122&#226;&#8364;&#8220;3132. [PubMed: 8608153] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Zhang Y, Desharnais J, Marsilje TH, Li C, Hedrick MP, Gooljarsingh LT, Tavassoli A, Benkovic SJ, <br />                                              Olson AJ, Boger DL, Wilson IA. Rational design, synthesis, evaluation, crystal structure a <br />                                              potent inhibitor human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8- <br />                                              tetrahydrofolic acid. Biochemistry 2003;42:6043&#226;&#8364;&#8220;6056. [PubMed: 12755606] <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                          Page 20 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           FIG. 1. 10-formyl-THF metabolism Leishmania <br />                                           Following synthesis activity dihydrofolate reductase (DHFR, encoded the <br />                                           bifunctional DHFR-TS) pteridine reductase 1 (PTR1), tetrahydrofolate (THF) enter C1 <br />                                           metabolic pathways direct formylation ATP-dependent reaction formate- <br />                                           tetrahydrofolate ligase (FTL, LmjF30.2600). Alternatively, THF converted 5,10- <br />                                           methylene-tetrahydrofolate (5,10-CH2-THF) activity serine <br />                                           hydroxymethyltransferase (SHMT). 10-CHO-THF generated steps 5,10- <br />                                           methylene-tetrahydrofolate (5,10-CH2-THF), oxidation 5,10-methenyl- <br />                                           tetrahydrofolate (5,10-CH=THF) NADP+-dependent methylenetetrahydrofolate <br />                                           dehydrogenase (DH, LmjF26.0320), hydrolysis 10-CHO-THF by <br />                                           methenyltetrahydrofolate cyclohydrolase (CH, LmjF26.0320). In L. major DH CH <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           activities contained single bifunctional protein DHCH1, like FTL localized <br />                                           exclusively cytosol (Vickers et al., 2008). While 10-CHO-THF used novo <br />                                           purine synthetic pathway organisms, pathway absent Leishmania many <br />                                           parasitic protozoans (Carter et al., 2008). Current data suggest 10-CHO-THF utilized <br />                                           mitochondrion methionyl-tRNA formylation, unique function far <br />                                           uncovered genomic metabolic studies Leishmania. <br />  <br />  <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                         Page 21 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           FIG. 2. Attempts generate dhch1&#226;&#710;&#8217; null mutants &#226;&#8364;&#732;classic&#226;&#8364;&#8482; double replacements <br />                                           A. Planned deletion DHCH1 ORF <span id='am-394' about='Thesaurus:Homologous_Gene' typeof='owl:Thing'>homologous gene</span> replacement using targeting <br />                                           fragments PAC HYG resistance markers. In round, parasites transfected <br />                                           construct separately; diagram round starting PAC shown. <br />                                           Heterozygous replacement lines obtained high efficiency. In second round, the <br />                                           +/PAC heterozygote (formally, &#206;&#8221;dhch1::PAC/DHCH) transfected HYG targeting <br />                                           fragment, expectation yielding homozogous dhch1&#226;&#710;&#8217; null mutants. Instead, only <br />                                           aneuploid parasites showing planned replacements retaining WT DHCH1 <br />                                           recovered (formally, &#206;&#8221;dhch1::PAC/DHCH/&#206;&#8221;dhch1::SAT/&#206;&#8221;dhch1::PAC/DHCH1). B. <br />                                           PCR tests planned PAC replacements DHCH1. Homologous replacement visualized <br />                                           PCR amplification using primer directed sequences located PAC ORF, <br />                                           primer located DHCH1 chromosome outside targeting fragment (indicated by <br />                                           heavy line) 5&#226;&#8364;&#178; (white arrows) 3&#226;&#8364;&#178; (black arrow) (SMB2731/2558 and <br />                                           SMB2771/2557, Table S1). The sizes predicted PCR products shown. WT, wild- <br />                                           type DNA; NC, negative control (no DNA template), #1&#226;&#8364;&#8220;8, independent lines with <br />                                           PAC replacements DHCH1. C, PCR tests planned HYG replacements DHCH1. This <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           experiment similar described panel B, primers directed against <br />                                           sequences located HYG targeting fragment (SMB2731/2562 SMB2771/2561, Table <br />                                           S1). #1&#226;&#8364;&#8220;6, independent lines HYG replacements DHCH1. D. PCR tests showing <br />                                           retention DHCH1 second round transfectants. Amplifications performed using <br />                                           primers directed sequences L. major DHCH1 ORF (SMB3125/3126, Table <br />                                           S1). Lines # 1 &#226;&#8364;&#8220; 4 represent double replacement PAC/HYG lines # 5 &#226;&#8364;&#8220; 8 HYG/ <br />                                           PAC. <br />  <br />  <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                       Page 22 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           FIG. 3. Deletion chromosomal DHCH1 presence ectopic DHCH1 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           A. Scheme deletion chromosomal DHCH1 presence ectopically expressed <br />                                           DHCH1. First, pXNG4-DHCH1 episomal expression construct transfected a <br />                                           DHCH1/&#206;&#8221;dhch1::PAC heterozygote described Fig. 2A; 10/10 transfectants analyzed were <br />                                           confirmed predicted genotype depicted. These DHCH1/&#206;&#8221;dhch1::PAC [pXNG4- <br />                                           DHCH1] lines transfected HYG DHCH targeting fragment selected for <br />                                           resistance antibiotics; 12 clonal lines tested, showed planned <br />                                           replacement chromosomal DHCH1 locus (formally, &#206;&#8221;dhch1::HYG DHCH1/ <br />                                           &#206;&#8221;dhch1::PAC [pXNG4-DHCH1]). <br />                                           B &#226;&#8364;&#8220; PCR tests showing loss chromosomal DHCH1. To distinguish ectopic DHCH1 <br />                                           chromosomal locus, DNA candidate lines subjected PCR tests using a <br />                                           using primer directed sequences located DHCH1 ORFt, primer located <br />                                           DHCH1 chromosome outside targeting fragment 5&#226;&#8364;&#178; (SMB2731/3126,, <br />                                           Table S1). WT, wild-type DNA control; NC, negative control lacking DNA template. The <br />  <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                      Page 23 <br />  <br />  <br />                                           arrow marks size predicted fragment WT DNA, absent the <br />                                           chromosomal dhch1&#226;&#710;&#8217; knockouts. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                          Page 24 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           FIG. 4. Deletion chromosomal DHCH1 presence ectopic FTL overexpression <br />                                           A. Scheme deletion chromosomal DHCH1 presence ectopically expressed <br />                                           FTL. A pXNG4-FTLepisomal expression construct transfected DHCH1/PAC <br />                                           (DHCH1/&#206;&#8221;dhch1::PAC) heterozygote described Fig. 2A; 10/10 transfectants analyzed had <br />                                           predicted genotype depicted. These DHCH1/PAC/+FTL lines (DHCH1/&#206;&#8221;dhch1::PAC <br />                                           [pXNG4-FTL]) transfected HYG DHCH1 targeting fragment described <br />                                           legend Fig. 3A; 12 clonal lines tested, showed planned replacement of <br />                                           chromosomal DHCH1 locus dhch1&#226;&#710;&#8217;/+FTL (&#206;&#8221;dhch1::HYG DHCH1/ <br />                                           &#206;&#8221;dhch1::PAC [pXNG4-FTL]). <br />                                           B &#226;&#8364;&#8220; PCR tests showing loss chromosomal DHCH1. This performed described in <br />                                           legend Fig. 3B. NC, negative control lacking DNA; WT, WT DNA; pXNG-DHCH1, <br />                                           WT transfected pXNG-DHCH1. Pac4, Pac5, Hyg7 different lines showing <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           absence predicted chromosomal DHCH1 PCR product (shown arrow). C. Western <br />                                           blot showing loss DHCH1 expression dhch1&#226;&#710;&#8217;/+FTL transfectants. The lines as <br />          <br /> </body></html>